Cardiology News

COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced new real-world evidence (RWE) demonstrating improved time in range (TIR) through the use of Welldoc’s Continuous Glucose Monitor (CGM)-informed insulin bolus calculator. For the millions of people who use bolus insulin, daily management is a burden. People with insulin-dependent diabetes make numerous, complex health-related decisions every day. When calculating a mealtime dose, in...

SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan announced today that it will have multiple presentations at ACC.26, taking place on March 28-30, 2026, in New Orleans....

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), pioneer of the novel nPulse™ platform using proprietary Nanosecond Pulsed Field Ablation (nsPFA™), today announced a new strategic alignment to prioritize and accelerate the development and future commercialization of its nPulse Cardiac Catheter Ablation System. “The European feasibility data from over 150 patients sends a definitive message,” said Bob Duggan, Co-Chairman of Pulse Biosciences. “The nPulse clinical perform...

PARIS--(BUSINESS WIRE)--Sensome announces successful proof-of-concept cases using its Clotild Smart Guidewire System in robotic thrombectomy, showing a path to Physical AI....

LIMA, Peru--(BUSINESS WIRE)--Johnson & Johnson announced the arrival in Peru of a new pulsed field ablation (PFA) technology for the treatment of drug-refractory paroxysmal atrial fibrillation. This incorporation represents a significant advance in the approach to cardiac arrhythmias, with benefits in terms of safety, precision, and procedural efficiency.1 "With this launch, Peru joins the Latin American countries that already have this world-class innovation, used in international referenc...

ALEXANDRIA, Va. & MIAMI--(BUSINESS WIRE)--AAO-HNSF and OpenEvidence use AI to update clinical practice guidelines and align standards of care with the latest clinical evidence as it evolves....

BOSTON & SHANGHAI--(BUSINESS WIRE)--Eccogene Announces First Patient Enrolled in MIST Phase 2a Trial Evaluating ECC4703 as an Adjunct to Semaglutide for the Treatment of Obesity...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new clinical data from the company’s cardio-pulmonary pipeline will be presented at the American College of Cardiology’s Annual Scientific Session and Expo (ACC.26) in New Orleans, La., from March 28-30. The results shared will highlight Merck’s unwavering commitment to advancing innovative research in hypercholesterolemia and in the syndrome of combined post- and precapillary...

NEW YORK--(BUSINESS WIRE)--ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter in ambulatory surgery centers (ASCs) across the United States. The agreement is designed to help physician-led ASCs gain earlier access to next-generation technology for treatment of cardiac arrhythmias in the ASC setting. Pulsed field ablation (PFA) is emerging as one of the most important advances in t...

BOSTON--(BUSINESS WIRE)--Form Health, the national leader in science-based obesity and cardiometabolic care, today announced it has joined Eli Lilly and Company's new Lilly Employer Connect platform, helping employers expand access to obesity management medications through flexible benefit design and more predictable pricing. Through Lilly Employer Connect, employers can work with independent program administrators like Form to design programs that expand access to obesity treatment while addre...